[VRDN] YoY Quarter Result on 30-Sep-2017 [#Q3]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
08-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 20.21%
YoY- -217.24%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 0 695 944 1,631 889 501 1,301 -
PBT -5,494 -11,230 -9,011 -5,834 -1,839 -3,152 -1,637 22.33%
Tax -48 133 362 113 0 0 0 -
NP -5,494 -11,230 -9,011 -5,834 -1,839 -3,152 -1,637 22.33%
Tax Rate - - - - - - - -
Total Cost 5,494 11,925 9,955 7,465 2,728 3,653 2,938 10.98%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin 0.00 -1,615.83 -954.56 -357.69 -206.86 -629.14 -125.84 -
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS -1.48 -5.42 -4.40 -4.06 -2.56 -5.82 -6.05 -20.89%
EPS Diluted -1.48 -5.42 -4.40 -4.06 -2.56 -5.82 -6.05 -20.89%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.